RolapitantRolapitant (INN, trade name Varubi in the US and Varuby in the European Union) is a drug originally developed by Schering-Plough and licensed for clinical development by Tesaro, which acts as a selective NK1 receptor antagonist (antagonist for the NK1 receptor). Read from the Drugbox of the Wikipedia article Rolapitant, revision 1368522467.

Property

Value

Formula

C25H26F6N2O2, 500.48 g/mol

Bioavailability

100 %

Protein binding

99.8 %

Elimination half-life

176 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.